A new study calls into question widely publicized U.S. results earlier this year suggesting that the drug tamoxifen prevents breast cancer in women at high risk of developing the disease. British scientists who conducted the longest-running study of tamoxifen have concluded that there isn't enough evidence the drug prevents breast cancer.